Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
29
CLB Quote, Financials, Valuation and Earnings
Last price:
$11.35
Seasonality move
:
0.33%
Day range:
$11.15 - $11.82
52-week range:
$10.14 - $25.13
Dividend yield:
0.34%
P/E ratio:
19.86x
P/S ratio:
1.08x
P/B ratio:
2.17x
Volume:
551.4K
Avg. volume:
545.1K
1-year change:
-30.86%
Market cap:
$549.5M
Revenue:
$523.8M
EPS (TTM):
$0.59
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $487.3M | $470.3M | $489.7M | $509.8M | $523.8M | |
| Revenue Growth (YoY) | -27.08% | -3.49% | 4.14% | 4.1% | 2.76% | |
| Cost of Revenues | $395.6M | $386.4M | $410.8M | $415.7M | $435.5M | |
| Gross Profit | $91.6M | $83.8M | $78.9M | $94M | $88.4M | |
| Gross Profit Margin | 18.81% | 17.83% | 16.12% | 18.45% | 16.87% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $34M | $43.9M | $37.6M | $38.9M | $38.6M | |
| Other Inc / (Exp) | -$134.4M | $5.3M | $177K | -$515K | $8.8M | |
| Operating Expenses | $34M | $43.9M | $37.6M | $38.9M | $38.6M | |
| Operating Income | $57.6M | $40M | $41.3M | $55.2M | $49.8M | |
| Net Interest Expenses | $14.4M | $9.2M | $11.6M | $13.4M | $12.4M | |
| EBT. Incl. Unusual Items | -$91.2M | $36.1M | $30M | $41.2M | $46.2M | |
| Earnings of Discontinued Ops. | -$424K | -- | -- | -- | -- | |
| Income Tax Expense | $5.9M | $15.9M | $10.3M | $4.2M | $14M | |
| Net Income to Company | -$96.9M | $20.2M | $19.7M | $37M | $32.2M | |
| Minority Interest in Earnings | -$140K | -$492K | -$205K | -$350K | -$753K | |
| Net Income to Common Excl Extra Items | -$97.6M | $19.7M | $19.5M | $36.7M | $31.4M | |
| Basic EPS (Cont. Ops) | -$2.20 | $0.43 | $0.42 | $0.79 | $0.67 | |
| Diluted EPS (Cont. Ops) | -$2.20 | $0.42 | $0.42 | $0.77 | $0.66 | |
| Weighted Average Basic Share | $44.5M | $46M | $46.3M | $46.7M | $46.9M | |
| Weighted Average Diluted Share | $44.5M | $46.7M | $46.8M | $47.5M | $47.7M | |
| EBITDA | -$55.9M | $63.8M | $58.7M | $70.4M | $73.5M | |
| EBIT | -$76.8M | $45.3M | $41.5M | $54.6M | $58.6M | |
| Revenue (Reported) | $487.3M | $470.3M | $489.7M | $509.8M | $523.8M | |
| Operating Income (Reported) | $57.6M | $40M | $41.3M | $55.2M | $49.8M | |
| Operating Income (Adjusted) | -$76.8M | $45.3M | $41.5M | $54.6M | $58.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $108.4M | $115.3M | $128.4M | $129.6M | $123.6M | |
| Revenue Growth (YoY) | -28.88% | 6.38% | 11.32% | 1% | -4.67% | |
| Cost of Revenues | $89M | $101.5M | $105.6M | $108.4M | $103.2M | |
| Gross Profit | $19.4M | $13.8M | $22.8M | $21.2M | $20.4M | |
| Gross Profit Margin | 17.86% | 11.96% | 17.75% | 16.36% | 16.51% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.5M | $15.9M | $16M | $11.5M | $13.4M | |
| Other Inc / (Exp) | $721K | $1.7M | -$298K | -$1.1M | -$2.6M | |
| Operating Expenses | $8.5M | $15.9M | $16M | $11.5M | $13.4M | |
| Operating Income | $10.9M | -$2.1M | $6.8M | $9.7M | $7M | |
| Net Interest Expenses | $1.4M | $2.6M | $3.4M | $3.4M | $2.6M | |
| EBT. Incl. Unusual Items | $10.3M | -$3M | $3.1M | $5.1M | $1.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1M | -$1.2M | $610K | $1.7M | $1.7M | |
| Net Income to Company | $8.2M | -$1.8M | $2.4M | $3.5M | $69K | |
| Minority Interest in Earnings | -$102K | -$49K | -$69K | -$270K | -$223K | |
| Net Income to Common Excl Extra Items | $8.1M | -$1.9M | $2.4M | $3.2M | -$154K | |
| Basic EPS (Cont. Ops) | $0.18 | -$0.04 | $0.05 | $0.07 | -- | |
| Diluted EPS (Cont. Ops) | $0.18 | -$0.04 | $0.05 | $0.07 | -- | |
| Weighted Average Basic Share | $45.2M | $46.3M | $46.6M | $46.9M | $46.8M | |
| Weighted Average Diluted Share | $46M | $46.3M | $47.5M | $47.7M | $46.8M | |
| EBITDA | $16.5M | $4.2M | $10.5M | $12.4M | $8.1M | |
| EBIT | $11.6M | -$391K | $6.5M | $8.6M | $4.4M | |
| Revenue (Reported) | $108.4M | $115.3M | $128.4M | $129.6M | $123.6M | |
| Operating Income (Reported) | $10.9M | -$2.1M | $6.8M | $9.7M | $7M | |
| Operating Income (Adjusted) | $11.6M | -$391K | $6.5M | $8.6M | $4.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $443.3M | $477.2M | $502.8M | $511.1M | $517.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $364.1M | $398.9M | $414.9M | $418.6M | $430.2M | |
| Gross Profit | $79.2M | $78.3M | $87.9M | $92.5M | $87.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21.6M | $51.2M | $41.2M | $34.7M | $40.7M | |
| Other Inc / (Exp) | -$13.8M | $6.2M | $1.7M | -$1M | $7.6M | |
| Operating Expenses | $21.6M | $51.2M | $41.2M | $34.7M | $40.7M | |
| Operating Income | $57.6M | $27.1M | $46.7M | $57.8M | $46.8M | |
| Net Interest Expenses | $12.3M | $10.4M | $12.4M | $13.4M | $11.5M | |
| EBT. Incl. Unusual Items | $31.5M | $22.8M | $36M | $43.3M | $42.9M | |
| Earnings of Discontinued Ops. | -$424K | -- | -- | -- | -- | |
| Income Tax Expense | $12M | $12.6M | $12.1M | $5.2M | $14.1M | |
| Net Income to Company | $19.6M | $10.2M | $23.9M | $38.1M | $28.7M | |
| Minority Interest in Earnings | -$159K | -$440K | -$225K | -$551K | -$706K | |
| Net Income to Common Excl Extra Items | $18.9M | $9.7M | $23.7M | $37.5M | $28M | |
| Basic EPS (Cont. Ops) | $0.42 | $0.21 | $0.50 | $0.81 | $0.60 | |
| Diluted EPS (Cont. Ops) | $0.42 | $0.21 | $0.50 | $0.78 | $0.59 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $64.1M | $51.5M | $65M | $72.3M | $69.2M | |
| EBIT | $43.8M | $33.2M | $48.4M | $56.7M | $54.4M | |
| Revenue (Reported) | $443.3M | $477.2M | $502.8M | $511.1M | $517.8M | |
| Operating Income (Reported) | $57.6M | $27.1M | $46.7M | $57.8M | $46.8M | |
| Operating Income (Adjusted) | $43.8M | $33.2M | $48.4M | $56.7M | $54.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $108.4M | $115.3M | $128.4M | $129.6M | $123.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $89M | $101.5M | $105.6M | $108.4M | $103.2M | |
| Gross Profit | $19.4M | $13.8M | $22.8M | $21.2M | $20.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.5M | $15.9M | $16M | $11.5M | $13.4M | |
| Other Inc / (Exp) | $721K | $1.7M | -$298K | -$1.1M | -$2.6M | |
| Operating Expenses | $8.5M | $15.9M | $16M | $11.5M | $13.4M | |
| Operating Income | $10.9M | -$2.1M | $6.8M | $9.7M | $7M | |
| Net Interest Expenses | $1.4M | $2.6M | $3.4M | $3.4M | $2.6M | |
| EBT. Incl. Unusual Items | $10.3M | -$3M | $3.1M | $5.1M | $1.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1M | -$1.2M | $610K | $1.7M | $1.7M | |
| Net Income to Company | $8.2M | -$1.8M | $2.4M | $3.5M | $69K | |
| Minority Interest in Earnings | -$102K | -$49K | -$69K | -$270K | -$223K | |
| Net Income to Common Excl Extra Items | $8.1M | -$1.9M | $2.4M | $3.2M | -$154K | |
| Basic EPS (Cont. Ops) | $0.18 | -$0.04 | $0.05 | $0.07 | -- | |
| Diluted EPS (Cont. Ops) | $0.18 | -$0.04 | $0.05 | $0.07 | -- | |
| Weighted Average Basic Share | $45.2M | $46.3M | $46.6M | $46.9M | $46.8M | |
| Weighted Average Diluted Share | $46M | $46.3M | $47.5M | $47.7M | $46.8M | |
| EBITDA | $16.5M | $4.2M | $10.5M | $12.4M | $8.1M | |
| EBIT | $11.6M | -$391K | $6.5M | $8.6M | $4.4M | |
| Revenue (Reported) | $108.4M | $115.3M | $128.4M | $129.6M | $123.6M | |
| Operating Income (Reported) | $10.9M | -$2.1M | $6.8M | $9.7M | $7M | |
| Operating Income (Adjusted) | $11.6M | -$391K | $6.5M | $8.6M | $4.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $13.8M | $17.7M | $15.4M | $15.1M | $19.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $83.2M | $96.8M | $106.9M | $109.4M | $111.8M | |
| Inventory | $38.2M | $45.4M | $60.4M | $71.7M | $59.4M | |
| Prepaid Expenses | $14.8M | $14.1M | $15.7M | $8.2M | $10.2M | |
| Other Current Assets | $6.2M | $5.1M | $5.1M | $5.1M | $10.5M | |
| Total Current Assets | $165.8M | $189.1M | $211.7M | $223.1M | $226.6M | |
| Property Plant And Equipment | $181.7M | $172.3M | $157.4M | $153.5M | $153.6M | |
| Long-Term Investments | $4.1M | $4.2M | $4.5M | $4.8M | $5.1M | |
| Goodwill | $99.4M | $99.4M | $99.4M | $99.4M | $99.4M | |
| Other Intangibles | $8.6M | $8.1M | $7.5M | $6.9M | $6.4M | |
| Other Long-Term Assets | $36.2M | $37.3M | $29.3M | $29.4M | $29.7M | |
| Total Assets | $568.6M | $580.9M | $578.4M | $586.4M | $590.4M | |
| Accounts Payable | $23M | $29.7M | $45.8M | $33.5M | $34.5M | |
| Accrued Expenses | $26.5M | $20.8M | $23.4M | $18.8M | $22.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $11.4M | $12.3M | $11.7M | $10.2M | $10.7M | |
| Other Current Liabilities | $8.4M | $7.7M | $8.4M | $7.7M | $8.2M | |
| Total Current Liabilities | $89.8M | $90.8M | $103.1M | $88.1M | $97.6M | |
| Long-Term Debt | $259.4M | $188.6M | $172.4M | $163.1M | $126.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $493M | $419.9M | $389.4M | $356.6M | $332.7M | |
| Common Stock | $1.1M | $1.2M | $1.2M | $469K | $470K | |
| Other Common Equity Adj | -$7.2M | -$10.1M | -$3.8M | -$5M | -$5.8M | |
| Common Equity | $71.5M | $156.4M | $184.3M | $224.8M | $252M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $4.1M | $4.6M | $4.7M | $5M | $5.7M | |
| Total Equity | $75.6M | $161M | $189M | $229.8M | $257.7M | |
| Total Liabilities and Equity | $568.6M | $580.9M | $578.4M | $586.4M | $590.4M | |
| Cash and Short Terms | $13.8M | $17.7M | $15.4M | $15.1M | $19.2M | |
| Total Debt | $259.4M | $188.6M | $172.4M | $163.1M | $126.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $27.8M | $22M | $16.3M | $14.9M | $22.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $86.6M | $98.9M | $110.7M | $115.1M | $117M | |
| Inventory | $39.1M | $48.2M | $67.3M | $70.7M | $59M | |
| Prepaid Expenses | $13.1M | $13.6M | $13.2M | $9.6M | $10.3M | |
| Other Current Assets | $5.8M | $4.8M | $6.6M | $4.3M | $6.3M | |
| Total Current Assets | $185.8M | $202.2M | $227.9M | $229M | $228.8M | |
| Property Plant And Equipment | $183.8M | $170.1M | $159M | $152.2M | $155.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $99.4M | $99.4M | $99.4M | $99.4M | $99.4M | |
| Other Intangibles | $8.4M | $8M | $7.3M | $6.8M | $6.3M | |
| Other Long-Term Assets | $39M | $37.5M | $32.9M | $34.2M | $34M | |
| Total Assets | $584.4M | $584.9M | $593.6M | $588M | $591.5M | |
| Accounts Payable | $25.5M | $34.4M | $38.4M | $32.5M | $38.5M | |
| Accrued Expenses | $23.1M | $26.5M | $23.5M | $20.2M | $24M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $12.4M | $12.7M | $11.1M | $10.4M | $11.7M | |
| Other Current Liabilities | $6.8M | $8M | $7.9M | $9.3M | $9.7M | |
| Total Current Liabilities | $85.5M | $99.8M | $95.6M | $85.5M | $103.7M | |
| Long-Term Debt | $208.2M | $189.8M | $180.4M | $160.4M | $124.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $438.4M | $418.5M | $393.5M | $350.5M | $332.2M | |
| Common Stock | $1.2M | $1.2M | $1.2M | $469K | $470K | |
| Other Common Equity Adj | -$7.9M | -$6.8M | -$3.5M | -$5.2M | -$5.9M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $4.2M | $4.6M | $4.8M | $5.3M | $6M | |
| Total Equity | $146M | $166.4M | $200.2M | $237.4M | $259.4M | |
| Total Liabilities and Equity | $584.4M | $584.9M | $593.6M | $588M | $591.5M | |
| Cash and Short Terms | $27.8M | $22M | $16.3M | $14.9M | $22.1M | |
| Total Debt | $208.2M | $189.8M | $180.4M | $160.4M | $124.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$96.9M | $20.2M | $19.7M | $37M | $32.2M | |
| Depreciation & Amoritzation | $20.9M | $18.5M | $17.2M | $15.8M | $15M | |
| Stock-Based Compensation | $7.4M | $19.1M | $7.8M | $14M | $3.8M | |
| Change in Accounts Receivable | $46.4M | -$13.5M | -$10.1M | -$2.6M | -$3.6M | |
| Change in Inventories | $1.5M | -$4.5M | -$14.9M | -$13M | $9.4M | |
| Cash From Operations | $57.9M | $36.6M | $25M | $24.8M | $56.4M | |
| Capital Expenditures | $12.4M | $13.9M | $10.2M | $10.6M | $13M | |
| Cash Acquisitions | -- | $873K | $240K | -- | -- | |
| Cash From Investing | $7.9M | -$10.2M | -$3.9M | -$6.7M | -$6.4M | |
| Dividends Paid (Ex Special Dividend) | -$12.4M | -$1.8M | -$1.9M | -$1.9M | -$1.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $56M | $155M | $116M | $202M | $44M | |
| Long-Term Debt Repaid | -$102M | -$226M | -$131M | -$211M | -$82M | |
| Repurchase of Common Stock | -$2.8M | -$8.3M | -$3.9M | -$2.2M | -$5.3M | |
| Other Financing Activities | -$1.8M | -$1.4M | -$2.6M | -$5.4M | -$775K | |
| Cash From Financing | -$63M | -$22.5M | -$23.4M | -$18.4M | -$46M | |
| Beginning Cash (CF) | $11.1M | $13.8M | $17.7M | $15.4M | $15.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.7M | $3.9M | -$2.3M | -$308K | $4M | |
| Ending Cash (CF) | $13.8M | $17.7M | $15.4M | $15.1M | $19.2M | |
| Levered Free Cash Flow | $45.5M | $22.7M | $14.7M | $14.2M | $43.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.2M | -$1.8M | $2.4M | $3.5M | $69K | |
| Depreciation & Amoritzation | $4.9M | $4.6M | $4M | $3.8M | $3.7M | |
| Stock-Based Compensation | $4.4M | $6.2M | $9M | $4.8M | $4.2M | |
| Change in Accounts Receivable | -$3.2M | -$2.8M | -$4M | -$6.3M | -$5.9M | |
| Change in Inventories | -$400K | -$2.5M | -$6.9M | $991K | -$272K | |
| Cash From Operations | $8M | $5.3M | -$3.2M | $5.5M | $6.7M | |
| Capital Expenditures | $2.9M | $2.3M | $2.2M | $3.1M | $3.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.1M | $428K | -$2M | -$1.7M | $772K | |
| Dividends Paid (Ex Special Dividend) | -$446K | -$463K | -$466K | -$468K | -$469K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $68M | $15M | $24M | $14M | $13M | |
| Long-Term Debt Repaid | -$119M | -$14M | -$16M | -$17M | -$15M | |
| Repurchase of Common Stock | -$171K | -$1.9M | -$1K | -$44K | -$2M | |
| Other Financing Activities | -$1.3M | -$1K | -$1.5M | -$568K | $9K | |
| Cash From Financing | $7.1M | -$1.4M | $6.1M | -$4.1M | -$4.5M | |
| Beginning Cash (CF) | $13.8M | $17.7M | $15.4M | $15.1M | $19.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $14M | $4.3M | $857K | -$207K | $3M | |
| Ending Cash (CF) | $27.8M | $22M | $16.3M | $14.9M | $22.1M | |
| Levered Free Cash Flow | $5.1M | $3M | -$5.4M | $2.5M | $3.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $19.6M | $10.2M | $23.9M | $38.1M | $28.7M | |
| Depreciation & Amoritzation | $20.3M | $18.2M | $16.6M | $15.6M | $14.8M | |
| Stock-Based Compensation | $1.3M | $20.9M | $10.5M | $9.8M | $3.1M | |
| Change in Accounts Receivable | $38.5M | -$13.2M | -$11.3M | -$4.9M | -$3.3M | |
| Change in Inventories | $3.4M | -$6.6M | -$19.3M | -$5.1M | $8.1M | |
| Cash From Operations | $43.8M | $33.9M | $16.5M | $33.5M | $57.5M | |
| Capital Expenditures | $11.8M | $13.3M | $10.1M | $11.4M | $13.6M | |
| Cash Acquisitions | -- | $873K | $240K | -- | -- | |
| Cash From Investing | $10.7M | -$8.7M | -$6.3M | -$6.3M | -$4M | |
| Dividends Paid (Ex Special Dividend) | -$1.8M | -$1.9M | -$1.9M | -$1.9M | -$1.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $107M | $102M | $125M | $192M | $43M | |
| Long-Term Debt Repaid | -$201M | -$121M | -$133M | -$212M | -$80M | |
| Repurchase of Common Stock | -$1.7M | -$10M | -$2M | -$2.2M | -$7.3M | |
| Other Financing Activities | -$3.1M | -$70K | -$4.1M | -$4.5M | -$198K | |
| Cash From Financing | -$40.6M | -$30.9M | -$15.9M | -$28.6M | -$46.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.9M | -$5.8M | -$5.8M | -$1.4M | $7.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $32M | $20.6M | $6.4M | $22.1M | $44M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.2M | -$1.8M | $2.4M | $3.5M | $69K | |
| Depreciation & Amoritzation | $4.9M | $4.6M | $4M | $3.8M | $3.7M | |
| Stock-Based Compensation | $4.4M | $6.2M | $9M | $4.8M | $4.2M | |
| Change in Accounts Receivable | -$3.2M | -$2.8M | -$4M | -$6.3M | -$5.9M | |
| Change in Inventories | -$400K | -$2.5M | -$6.9M | $991K | -$272K | |
| Cash From Operations | $8M | $5.3M | -$3.2M | $5.5M | $6.7M | |
| Capital Expenditures | $2.9M | $2.3M | $2.2M | $3.1M | $3.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.1M | $428K | -$2M | -$1.7M | $772K | |
| Dividends Paid (Ex Special Dividend) | -$446K | -$463K | -$466K | -$468K | -$469K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $68M | $15M | $24M | $14M | $13M | |
| Long-Term Debt Repaid | -$119M | -$14M | -$16M | -$17M | -$15M | |
| Repurchase of Common Stock | -$171K | -$1.9M | -$1K | -$44K | -$2M | |
| Other Financing Activities | -$1.3M | -$1K | -$1.5M | -$568K | $9K | |
| Cash From Financing | $7.1M | -$1.4M | $6.1M | -$4.1M | -$4.5M | |
| Beginning Cash (CF) | $13.8M | $17.7M | $15.4M | $15.1M | $19.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $14M | $4.3M | $857K | -$207K | $3M | |
| Ending Cash (CF) | $27.8M | $22M | $16.3M | $14.9M | $22.1M | |
| Levered Free Cash Flow | $5.1M | $3M | -$5.4M | $2.5M | $3.1M | |
Get CLB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLB
Sector
P/E ratio
19.86x
10.08x
PEG ratio
0.36x
0.01x
P/B ratio
2.17x
0.95x
Price / LTM sales
1.08x
0.81x
Growth Metrics
CLB
Sector
Revenue growth
-4.67%
-4.16%
Earnings growth
-100%
-18.66%
Revenue (5-year growth)
-4.75%
6.57%
Earnings forecast
$0.15
$0.21
Profitability
CLB
Sector
Profitability FY 2024
$88.4M
$104.4M
Return on invested capital
7.17%
3.77%
Return on assets
4.72%
2.63%
Return on equity
11.15%
5.83%
Earnings Date
Last Earnings Date
Apr
23
Next Earnings Date
Jul
24
Estimated Next Earnings Date
Jul
23
Balance Sheet
CLB
Sector
Total cash
$22.1M
$14.6M
Short term investments
--
$3.5M
Total assets
$590.4M
$406.5M
Long term debt
$124.4M
$125.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.99% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 2% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 4.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
